Life science News and Research

RSS

Synageva receives $2.3 million under QTDP program

Synageva BioPharma Corp., a privately held biopharmaceutical company developing novel treatments for rare diseases, today announced that the US Treasury Department awarded approximately $2.3 million to Synageva BioPharma as part of the Qualifying Therapeutic Discovery Project Program.

4 Nov 2010

Ingenuity Systems and Geospiza partner to enable seamless next-generation sequencing analysis workflow

Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.

3 Nov 2010

Harvard Bioscience third quarter revenue increases 26.0% to $26.5 million

Harvard Bioscience, Inc. a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the three and nine months ended September 30, 2010.

From Harvard Bioscience 3 Nov 2010

Waters launches new program to support scientific innovation

Waters Corporation today launched a new program to support scientific innovation in the fields of health and life science research, sports science, food safety, clinical research and environmental protection.

3 Nov 2010

Cold Spring Harbor Protocols features standard and cutting-edge imaging laboratory techniques

Imaging has rapidly become a defining tool of the current era in biological research. But finding the right method and optimizing it for data collection can be a daunting process, even for an established imaging laboratory. Cold Spring Harbor Protocols is one of the world's leading sources for detailed technical instruction for implementation of imaging methods, and the November issue features articles detailing standard and cutting-edge laboratory techniques.

2 Nov 2010

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.

1 Nov 2010

Medicago receives Health Canada clearance for Phase II clinical trial of H5N1 Avian Influenza vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has received clearance from Health Canada to commence a Phase II human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrolment of volunteers is now underway.

1 Nov 2010

Vascular Pathways closes $14 million Series B equity financing round

Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.

1 Nov 2010

Life Technologies announces launch of new sequencer to deliver genomic data

Life Technologies Corporation a provider of innovative life science solutions, today announced the launch of the 5500xl SOLiD Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.

1 Nov 2010

Value of medical innovation far outstrips its cost, says Lilly CEO

In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, said that the value of medical innovation – particularly innovative medicines – far outstrips its cost. Lechleiter marshaled data showing that medical innovation over the past century dramatically extended life spans, improved quality of life, and boosted productivity.

30 Oct 2010

ZyGEM announces advancement in microfluidics platform for DNA testing

ZyGEM Corp. Ltd., today announced several developments supporting the advancement of its integrated microfluidics platform designed to dramatically decrease the time, complexity and cost of conducting DNA testing. These include presentations at two key scientific meetings, as well as the issuance of a new patent relating to separation technology that supports and further strengthens ZyGEM's intellectual property portfolio.

29 Oct 2010

IntegraGen to open subsidiary in Cambridge, Massachusetts

IntegraGen, Inc., a French biotechnology company dedicated to gene discovery and the development of molecular diagnostic products and services, announced today that it is expanding its operations by opening a U.S. subsidiary headquartered in Cambridge, Massachusetts that will support the company's clinical research initiatives focused on the early identification of children at risk of autism. IntegraGen will open the new office on November 1, 2010.

28 Oct 2010

Global supply of medical products create demanding challenges for Life Sciences industry

An extensive research study by Axendia, Inc., co-sponsored by Camstar Systems, Inc., shows that globalization of manufacturing and supply of medical products has created unique and demanding challenges for the Life Sciences industry. The cost advantages of global manufacturing and outsourcing are tempered by the need to improve product safety and reduce risks.

28 Oct 2010

Addition of ECC probe to SOLiD System's chemistry achieves greater than 99.99% single-read accuracy

Life Technologies Corporation a provider of innovative life science solutions, today announced that it has established a new standard in accuracy for next generation sequencing. By adding an Exact Call Chemistry (ECC) proprietary probe to its market leading ligation chemistry, the company has demonstrated greater than 99.99% average single-read accuracy.

27 Oct 2010

Tripos releases new version of SYBYL-X for QSAR studies

Tripos, a leading provider of drug discovery informatics products and services, today announced the release and general availability of SYBYL-X Version 1.2.

27 Oct 2010

Omeros to develop new drugs for major diseases

The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.

26 Oct 2010

DKSH’s distribution centers achieve GMP/GDP certification

On the occasion of DKSH's Annual Logistics and Quality Seminar in Taipei, Business Unit Healthcare organized a Certification Award Ceremony to acknowledge the great success of the certification program. It was presided by Charles Toomey, Executive Vice President Business Unit Healthcare, and Dr. Eize de Boer from SGS (Société Générale de Surveillance).

26 Oct 2010

Panasonic completes investment in CardioNexus

Panasonic Corporation of North America has completed an investment in CardioNexus Corporation, a portfolio company of Houston's Fairway Medical Technologies which works closely with the Texas Medical Center. The move is part of Panasonic's plans to establish itself as a global leader in Personalized Preventive Medicine. The investment follows on an earlier Panasonic initiative to establish a presence in the world's largest medical complex, the Texas Medical Center based in Houston.

From PHC Europe B.V. 26 Oct 2010

Maven Semantic updates Lymphocyte Cell Biology research database

Maven Semantic announces updates to their Lymphocyte Cell Biology research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

26 Oct 2010

ATMI and Austar open new Chinese manufacturing facility

ATMI, Inc. today announced that it has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar, a Hong Kong-based comprehensive service provider to the China pharmaceutical industry.

25 Oct 2010